Metabolic Syndrome and COVID-19 Outcomes: Implications for Disease Burden
Metabolic syndrome is associated with an increased risk of acute respiratory distress syndrome (ARDS) and death from COVID-19, providing insights into the disproportionate impact of COVID-19 on individuals with metabolic comorbidities and underlying cardiometabolic dysfunction.
September 2022
Reduced Blood Pressure and Type 2 Diabetes Risk: Clinical Observations
Reducing systolic blood pressure by 5 mm Hg is associated with a lower risk of developing type 2 diabetes, highlighting the potential cardiometabolic benefits of blood pressure management in preventing diabetes onset and improving metabolic health.
September 2022
Global Dementia Cases to Triple by 2050: Study Identifies Risk Factors
A study analyzing risk factors for dementia predicts a tripling of global dementia cases by 2050, emphasizing the need for preventive strategies targeting modifiable risk factors such as smoking, obesity, diabetes, and low educational attainment.
August 2022
Mild Autonomous Cortisol Secretion in Adrenal Incidentalomas: Prevalence and Clinical Implications
Researchers reveal the prevalence of mild autonomous cortisol secretion in adrenal incidentalomas, a condition associated with an increased risk of type 2 diabetes and hypertension, highlighting the importance of early detection and management in affected individuals.
August 2022
Contraceptives in Polycystic Ovary Syndrome: Impact on Diabetes Risk
Contraceptive pills reduce the risk of type 2 diabetes by more than a quarter in women with polycystic ovary syndrome, highlighting the potential role of hormonal contraceptives in mitigating metabolic complications associated with PCOS.
June 2022
Osteoarthritis, Obesity, and Type 2 Diabetes: Exploring the Interplay and Clinical Implications
Review explores the links between obesity, type 2 diabetes, and osteoarthritis, focusing on the impact of ectopic (intra-abdominal) fat distribution on disease pathogenesis and progression, with implications for targeted interventions and multidisciplinary management approaches.
Februery 2022
Pregabalin in Diabetic Neuropathy: Prevalence and Management
Pregabalin is identified as one of the most common treatments for diabetic peripheral neuropathy, with a high prevalence of neuropathic pain among diabetic patients, highlighting the need for targeted pharmacological interventions to alleviate symptoms and improve quality of life.
November 2021
Obesity and Hyperinsulinemia: Pathophysiological Interplay and Clinical Implications
The adverse consequences attributed to obesity may be mediated by hyperinsulinemia, suggesting a complex interplay between metabolic and hormonal factors in obesity-related complications and underscoring the importance of targeted interventions in managing obesity-related health risks.
November 2021
